Barely Significant
← all excerpts

Design, Characterization, and Immune Augmentation of Docosahexaenoic Acid Nanovesicles as a Potential Delivery System for Recombinant HBsAg Protein.

Vaccines (Basel) · 2022 · PMC9231307 · PMID 35746563

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

extremely significantp < 0.01actually significant
On the 30th day of the product (LRPDNV) administration, the antibody level was 26.66 0.7 U/mL, which was extremely significant at the p < 0.01 level when compared to the antibody level on the 14th day in the product treatment group.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.